Person-centred prophylaxis for venous thromboembolism

Area of Science:

• Internal Medicine
• Pharmacology
• Clinical Risk Management

Background:

• Medical admissions necessitate risk assessment for venous thromboembolism (VTE) prophylaxis.
• The risk of VTE is often balanced against the risk of bleeding, which can be exacerbated by chemical prophylaxis.
• Current guidelines recommend prophylaxis when VTE risk outweighs bleeding risk.

Purpose of the Study:

• To evaluate the effectiveness of current risk assessment tools for VTE prophylaxis in medical admissions.
• To highlight the limitations of existing UK-based risk assessment tools in balancing VTE and bleeding risks.
• To advocate for the adoption of validated risk scoring systems for improved prophylaxis targeting.

Main Methods:

• Review of current NICE guidelines on VTE prophylaxis.
• Analysis of the Department of Health Risk Assessment Tool's limitations.
• Comparison with validated risk scoring systems used internationally.

Main Results:

• NICE guidelines emphasize comprehensive risk assessment for VTE prophylaxis.
• The Department of Health Risk Assessment Tool does not adequately rank VTE versus bleeding risks.
• Validated risk scores are utilized internationally for more precise prophylaxis decisions.

Conclusions:

• There is a need for improved risk stratification tools in the UK for VTE prophylaxis.
• Validated risk scores could facilitate safer and more targeted prophylaxis in medical admissions.
• Further research is required to implement effective risk-scoring tools in the UK healthcare system.